Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants

被引：0
|
作者：
Vidya Perera
Grigor Abelian
Danshi Li
Zhaoqing Wang
Liping Zhang
Susan Lubin
Wei Chen
Akintunde Bello
Bindu Murthy
机构：
[1] Early Clinical and Translational Research,Global Clinical Pharmacology
[2] Bristol Myers Squibb,undefined
[3] Janssen Research & Development,undefined
[4] LLC,undefined
来源：
Clinical Pharmacokinetics | 2022年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：857 / 867
页数：10
相关论文
共 50 条
  • [41] Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment
    John Marcinak
    Majid Vakilynejad
    Akifumi Kogame
    Yoshihiko Tagawa
    [J]. Drugs in R&D, 2018, 18 : 109 - 118
  • [42] Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment
    Marcinak, John
    Vakilynejad, Majid
    Kogame, Akifumi
    Tagawa, Yoshihiko
    [J]. DRUGS IN R&D, 2018, 18 (02) : 109 - 118
  • [43] Effect of mild and moderate hepatic impairment on azimilide pharmacokinetics following single dose oral administration
    Corey, AE
    Agnew, JR
    King, EC
    Parekh, NJ
    Powell, JH
    Thompson, GA
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (05) : 1279 - 1286
  • [44] Single-Dose Tolerability and Pharmacokinetics of Onradivir in Chinese Patients with Hepatic Impairment and Healthy Matched Controls
    Li, Cuiyun
    Li, Haijun
    Mai, Jiajia
    Zhang, Hong
    Wu, Min
    Ding, Yanhua
    Huang, Jufang
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [45] SINGLE-DOSE PHARMACOKINETICS OF BMS-986177/JNJ-70033093 (BMS-177/JNJ-3093) IN PARTICIPANTS WITH NORMAL RENAL FUNCTION AND PARTICIPANTS WITH MODERATE OR SEVERE RENAL IMPAIRMENT
    Perera, Vidya
    Abelian, Grigor
    Li, Danshi
    Wang, Zhaoqing
    Zhang, Liping
    Lubin, Susan
    Bello, Akintunde
    Murthy, Bindu
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1839 - 1839
  • [46] Single-dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants
    Devineni, Damayanthi
    Polidori, David
    Curtin, Christopher
    Stieltjes, Hans
    Tian, Hong
    Wajs, Ewa
    [J]. CLINICAL THERAPEUTICS, 2016, 38 (01) : 89 - 98
  • [47] Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activityof Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment
    Lefebvre, E.
    Gottwald, M.
    Lasseter, K.
    Chang, W.
    Willett, M.
    Smith, P. F.
    Somasunderam, A.
    Utay, N. S.
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2016, 9 (03): : 139 - 148
  • [48] Pharmacokinetics of JNJ-73763989 and JNJ-56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment
    Kakuda, Thomas N. N.
    Halabi, Atef
    Klein, Gernot
    Sanga, Madhu
    Guinard-Azadian, Carine
    Kowalik, Monika
    Nedoschinsky, Katja
    Nangosyah, Julius
    Ediage, Emmanuel Njumbe
    Hillewaert, Vera
    Verboven, Peter
    Goris, Ivo
    Snoeys, Jan
    Palmer, Martyn
    Biermer, Michael
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (06): : 732 - 741
  • [49] PHARMACOKINETICS AND SAFETY OF VIR-2218 MONOTHERAPY IN ADULT CIRRHOTIC PARTICIPANTS WITH MODERATE HEPATIC IMPAIRMENT
    Wang, Li
    Chattergoon, Michael A.
    Elie, Sophia
    Wu, Pan
    Hristopoulos, George
    Gupta, Sneha
    Reyes, Maribel
    [J]. HEPATOLOGY, 2023, 78 : S581 - S582
  • [50] Single-dose pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment
    de Jonga, Jan
    Skee, Donna
    Hellemans, Peter
    Jiao, James
    de Vries, Ronald
    Swerts, Dominique
    Lawitz, Eric
    Marbury, Thomas
    Smith, William
    Sukbuntherng, Juthamas
    Mannaert, Erik
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 185 - 194
12345